NIH appoints Dr. Greg Simon to Precision Medicine advisory panel
Group Health psychiatrist and researcher will be among national leaders advising on Initiative’s Cohort Program
SEATTLE—The National Institutes of Health (NIH) has appointed Gregory Simon, MD, MPH, as a member of the advisory panel for the President’s Precision Medicine Initiative’s Cohort Program. Dr. Simon is a Group Health psychiatrist, a senior investigator at Group Health Research Institute, and chair of the Depression and Bipolar Support Alliance’s Scientific Advisory Board.
“People living with mental health conditions have a wide range of treatment options, but we need better evidence to help them choose,” Dr. Simon said. “The Precision Medicine Initiative hopes to substitute science for what’s now decided by trial and error.”
Read our news release: Dr. Gregory Simon appointed to Precision Medicine advisory board.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.